About Mphasis

Mphasis Limited is an Indian information technology services company specialising in cloud and cognitive services, digital platform engineering, application development, maintenance and support, as well as infrastructure services. It serves clients across Banking & Financial Services, Insurance, Technology, Media & Telecom, Logistics & Transportation, among others. With strong presence in the Americas, Mphasis combines direct core business (digital, cloud, AI-driven) with legacy/partnered segments such as work via clients like DXC, enabling both opportunity and challenge in its growth mix.

What UBS Sees for Mphasis

• UBS has initiated a Buy rating on Mphasis with a target price of ₹3,370 per share.
• They believe near-term revenue growth has room to recover, and much of that potential is not yet reflected in the current share price.
• Challenges arising from DXC exposure, Digital Risk operations, and vertical-specific slowdowns are now largely easing.
• They forecast revenue growth to accelerate over FY25-28 with CAGR of around 10%, compared to only ~2% over FY22-25.
• Current valuation, in UBS’s view, reflects only a modest CAGR (7-8%) over FY25-30 — below their estimated potential (~11%).

Analysis and Key Drivers

The UBS thesis rests on several pillars:

1. Easing Headwinds: Major drag from the DXC-partnered business and the Digital Risk acquisition are believed to be stabilising. As risks from those segments recede, margin pressures and uncertainty are expected to reduce.
2. Acceleration in Direct Business: Mphasis’s direct core business — especially in digital, cloud, AI, and platform engineering — is projected to pick up faster. UBS expects this to drive much of the growth in FY25-28.
3. Vertical Diversification: With sector-specific bottlenecks (e.g. in certain tech or BFS verticals) showing signs of relief, there is room for more balanced performance across business segments.
4. Valuation Gap: UBS estimates that current share price does not fully incorporate the higher growth forecast. If Mphasis delivers the ~10-11% CAGR UBS expects, the upside could be meaningful.

Impacts on Business and Risks

While UBS’s outlook is generally bullish, several risks and implications merit attention:

• Dependence on Legacy/Partnered Segments: DXC-related revenue has been volatile; Digital Risk acquisition had been under scrutiny for margin dilution. If these don’t improve as expected, growth may underperform.
• Margin Pressure: As revenue mix shifts, investments in cloud, AI, new technologies, talent, and adapting to changing demand could compress margins before they recover.
• Foreign Exchange & Macro Risks: Unfavourable currency movements or global tech spend slowdowns can affect topline and profitability.
• Execution Risks: Scaling direct core business, closing digital transformation deals, maintaining service quality — all areas requiring execution excellence.

Investor takeaway

If the assumptions laid out by UBS play out — easing headwinds, acceleration in direct business, revenue CAGR of ~10-11% between FY25-28, and improved margin discipline — Mphasis could be significantly undervalued at current levels. For long-term investors, this could present a compelling entry point, provided risk factors are closely monitored.

For traders positioning for this turnaround, check out reliable guidance below:
👉 Nifty Tip | BankNifty Tip
📌 Read fresh insights at Indian-Share-Tips.com, offering SEBI-Registered Advisory Services.

What Could Go Wrong

• If recovery in verticals or in DXC/partner business lags, UBS’s growth forecasts may prove optimistic.
• Increased competition in digital/cloud/AI may force pricing pressure or higher investment, delaying margin improvement.
• Regulatory changes, visa or trade policy shifts can impact global delivery models.
• Currency volatility or macroeconomic headwinds in client geographies (especially the US & Europe) could impact both revenue and cost base.

Should You Consider Buying Mphasis Now?

For investors comfortable with some risk, Mphasis appears to offer **upside**. The current market price seems to under-discount key positives: easing drag, acceleration in high-growth segments, and favourable valuation tailwinds. Short-term fluctuations may occur, but the medium-term outlook (FY25-28) looks promising under UBS’s thesis.

Disclaimer: This article is for informational purposes only. Readers should conduct their own due diligence or consult a financial advisor before making investment decisions. Indian-Share-Tips.com does not guarantee returns and disclaims any liability arising from investment actions based on this content.

MPHASIS, UBS Rating, IT Services India, Revenue Growth Forecast, Digital Transformation, DXC Exposure, Stock Analysis